Please login to the form below

Not currently logged in
Email:
Password:

Organogenesis

This page shows the latest Organogenesis news and features for those working in and with pharma, biotech and healthcare.

Shire pays record $350m to settle US kickback allegations

Shire pays record $350m to settle US kickback allegations

Dermagraft has proved to be something of an expensive debacle for Shire, which took a $650m charge when it offloaded the product to Organogenesis, a decision prompted by its failure to

Latest news

  • Shire faces $650m loss on Dermagraft sale Shire faces $650m loss on Dermagraft sale

    Shire faces $650m loss on Dermagraft sale. Sells struggling foot ulcer treatment to Organogenesis. ... Organogenesis now owns the rights to all Dermagraft assets, including patents, product inventory and certain manufacturing equipment.

  • Improving the prospects for ATMPs in Europe

    Established products include Shire subsidiary Advanced Biohealing's Dermagraft, which is already generating sales of around $200m a year, and Novartis/Organogenesis' Apligraf, both of which are based on allogeneic cells

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch table for January 2014 Deal Watch table for January 2014

    320. Shire/ Organogenesis. Divestment. Shire's sale of its Dermagraft assets acquired as part of Advanced BioHealing.

  • Pharma deals during January 2014 Pharma deals during January 2014

    The Merck &Co divestment of Sirna is noted above but, this month, Shire announced the divestment of Dermagraft (a bioengineered skin substitution product for diabetic foot ulcers) to Organogenesis.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Vifor Pharma appoints Dario Eklund Vifor Pharma appoints Dario Eklund

    Eklund joins from Organogenesis, a regenerative medicine company which focuses in wound healing and soft tissue regeneration, where he was VP with responsibility for non-US operations, business development and licensing

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
FCB Halesway

A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics